Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSV | O60911 | 4/20 | 1.00 |
| ▸ | CTSL | P07711 | 4/20 | 1.00 |
| ▸ | GHSR | Q92847 | 3/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | PARP1 | P09874 | 1/20 | 0.51 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21065454 | 1.00 | CTSV (1.00) | CTSVCTSLGHSRHSD17B10KDM4E | |
| SCHEMBL26993704 | 1.00 | CTSV (1.00) | CTSVCTSLGHSRHSD17B10KDM4E | |
| SCHEMBL30472916 | 1.00 | CTSV (1.00) | CTSVCTSLGHSRHSD17B10KDM4E | |
| SCHEMBL25422114 | 1.00 | CTSV (1.00) | CTSVCTSLGHSRHSD17B10KDM4E | |
| SCHEMBL472759 | 1.00 | CTSV (1.00) | CTSVCTSLGHSRHSD17B10KDM4E | |
| SCHEMBL25424145 | 1.00 | CTSV (1.00) | CTSVCTSLGHSRHSD17B10KDM4E | |
| SCHEMBL30913016 | 1.00 | CTSV (1.00) | CTSVCTSLGHSRHSD17B10KDM4E | |
| SCHEMBL29411985 | 1.00 | CTSV (1.00) | CTSVCTSLGHSRHSD17B10KDM4E | |
| SCHEMBL2821600 | 0.98 | CTSV (0.97) | CTSVCTSLGHSRHSD17B10KDM4E | |
| SCHEMBL7835926 | 0.94 | CTSV (0.88) | CTSVCTSLGHSRHSD17B10KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118063452-A | Benzothiazole or benzoxazole derivative and preparation method and application thereof | 山东大学 | 2024-05-24 | — | — | CN | disclosed |
| CN-115477610-B | Preparation method of C-3 perfluoroalkyl 4-quinolinone compound | 河北农业大学 | 2024-03-15 | — | — | CN | disclosed |
| US-20230184759-A1 | IN VITRO METHOD FOR DETECTION OF INFECTIONS CAUSED BY PSEUDOMONAS AERUGINOSA | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (ES) | 2023-06-15 | — | — | US | disclosed |
| CN-115968368-A | Quinolone compound and preparation method thereof | 科学和工业研究理事会是印度注册的机构(1860年第XXI号法案) | 2023-04-14 | — | — | CN | disclosed |
| CN-115477610-A | Preparation method of C-3 perfluoroalkyl 4-quinolinone compounds | 河北农业大学 | 2022-12-16 | — | — | CN | disclosed |
| CN-107667288-B | Spectral analysis of microorganisms | 英国质谱公司 | 2022-02-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230184759-A1 | IN VITRO METHOD FOR DETECTION OF INFECTIONS CAUSED BY PSEUDOMONAS AERUGINOSA | QSOX1, QARS1, CD47 | CTSV 4321/4885CTSL 3138/4885GHSR 1122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.